Home
About
Overview
Sharing Data
ORCID
Help
History (47)
Model systems for flavoenzyme activity: site-isolated redox behavior in flavin-functionalized random polystyrene copolymers.
Correlations between kinematic and rating scale measures of tardive dyskinesia in a developmentally disabled population.
Effects of the August 2003 blackout on the New York City healthcare delivery system: a lesson for disaster preparedness.
Functionalized gold nanoparticles for drug delivery.
Varenicline for smoking cessation in patients with coronary heart disease.
See All 47 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Varenicline for smoking cessation in patients with coronary heart disease.
Ockene I, Salmoirago-Blotcher E. Varenicline for smoking cessation in patients with coronary heart disease. Circulation. 2010 Jan 19; 121(2):188-90.
View in:
PubMed
subject areas
Benzazepines
Cardiovascular Diseases
Coronary Disease
Drug-Related Side Effects and Adverse Reactions
Humans
Quinoxalines
Smoking Cessation
Treatment Outcome
Varenicline